Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients

Immune thrombocytopenia (ITP) is a disorder in which autoantibodies are responsible for destruction and decreased production of platelets. In the meantime, thrombocytopenia is frequent in patients with myelodysplastic syndromes (MDS) and immune clearance of megakaryocytes could be a reason. The aim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of hematology 2021-07, Vol.100 (7), p.1701-1709
Hauptverfasser: Elzaeem, Doaa I., Sharkawi, Esmat A. El, Zaki, Eman M., Ghobrial, Ayman G., El-Fatah, Aliaa S. Abd, El-Hamed, Waleed M. Abd
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1709
container_issue 7
container_start_page 1701
container_title Annals of hematology
container_volume 100
creator Elzaeem, Doaa I.
Sharkawi, Esmat A. El
Zaki, Eman M.
Ghobrial, Ayman G.
El-Fatah, Aliaa S. Abd
El-Hamed, Waleed M. Abd
description Immune thrombocytopenia (ITP) is a disorder in which autoantibodies are responsible for destruction and decreased production of platelets. In the meantime, thrombocytopenia is frequent in patients with myelodysplastic syndromes (MDS) and immune clearance of megakaryocytes could be a reason. The aim of the present study is to evaluate and compare IgG binding to megakaryocytes in bone marrow of ITP and MDS patients to determine megakaryocytes targeting by autoantibodies in vivo as a mechanism of platelet underproduction in these disorders. The study was carried out on 20 ITP (group I) patients, 20 thrombocytopenic patients with (MDS) (group II), and 20 non-ITP patients as a control (group III) who were admitted to Minia University Hospital. Serial histological sections from bone marrow biopsies were stained for IgG. All patients in group I and 50% of group II patients showed bleeding tendency and the difference was significant (p 
doi_str_mv 10.1007/s00277-021-04556-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2526305430</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2526305430</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-31668d4eeb27fbc93d2f0939ed26546a6225bd9395bed879007313b3335e0ea93</originalsourceid><addsrcrecordid>eNp9kU9v3CAQxVGVqNmk_QI9VEi59OIEGOM_x2qVJpEi5ZKeETbjrbcGXMCR_O3DdtNWyqFzGWn4zQPeI-QTZ1ecsfo6MibqumCCF6yUsirEO7LhJYiCyaY8IRvWQlvIXGfkPMY9Y1w0pXhPzgDaRnCoNmS_9XbWQafxGWlMi1mpH-j97pZ2ozOj29HkqcWd_qnD6vs1YaSjo6O1i0OqnaF2xcmbNc6TjmnsafoRvO0OqJ_R5cGcxdGl-IGcDnqK-PG1X5Dv326etnfFw-Pt_fbrQ9FDLVMBvKoaUyJ2oh66vgUjhsNH0IhKlpWuhJCdyQPZoWnqNjsBHDoAkMhQt3BBvhx15-B_LRiTsmPscZq0Q79EJaSogMkSWEYv36B7vwSXX5epkmXDai4yJY5UH3yMAQc1h9FmPxRn6pCEOiahchLqdxLqsPT5VXrpLJq_K3-szwAcgZiP3A7Dv7v_I_sCbHWUdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2540001712</pqid></control><display><type>article</type><title>Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients</title><source>SpringerLink Journals</source><creator>Elzaeem, Doaa I. ; Sharkawi, Esmat A. El ; Zaki, Eman M. ; Ghobrial, Ayman G. ; El-Fatah, Aliaa S. Abd ; El-Hamed, Waleed M. Abd</creator><creatorcontrib>Elzaeem, Doaa I. ; Sharkawi, Esmat A. El ; Zaki, Eman M. ; Ghobrial, Ayman G. ; El-Fatah, Aliaa S. Abd ; El-Hamed, Waleed M. Abd</creatorcontrib><description>Immune thrombocytopenia (ITP) is a disorder in which autoantibodies are responsible for destruction and decreased production of platelets. In the meantime, thrombocytopenia is frequent in patients with myelodysplastic syndromes (MDS) and immune clearance of megakaryocytes could be a reason. The aim of the present study is to evaluate and compare IgG binding to megakaryocytes in bone marrow of ITP and MDS patients to determine megakaryocytes targeting by autoantibodies in vivo as a mechanism of platelet underproduction in these disorders. The study was carried out on 20 ITP (group I) patients, 20 thrombocytopenic patients with (MDS) (group II), and 20 non-ITP patients as a control (group III) who were admitted to Minia University Hospital. Serial histological sections from bone marrow biopsies were stained for IgG. All patients in group I and 50% of group II patients showed bleeding tendency and the difference was significant (p &lt; 0.001). No patient experienced fatigue in group I while 35% of patients in group II complained of easy fatigability, and the difference was significant (p &lt; 0.008). High IgG antibody binding was found in ITP and MDS compared to the control group but no significant difference between ITP and MDS patients (14/20 (70%) vs. 13/20 (65%)) (p value = 0.736). Antibody binding to megakaryocytes in a proportion of MDS patients suggests that immune-mediated mechanism underlies platelet underproduction in those patients.</description><identifier>ISSN: 0939-5555</identifier><identifier>EISSN: 1432-0584</identifier><identifier>DOI: 10.1007/s00277-021-04556-2</identifier><identifier>PMID: 33982136</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Bone marrow ; Hematology ; Medicine ; Medicine &amp; Public Health ; Myelodysplastic syndromes ; Oncology ; Original Article ; Thrombocytopenia</subject><ispartof>Annals of hematology, 2021-07, Vol.100 (7), p.1701-1709</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-31668d4eeb27fbc93d2f0939ed26546a6225bd9395bed879007313b3335e0ea93</citedby><cites>FETCH-LOGICAL-c375t-31668d4eeb27fbc93d2f0939ed26546a6225bd9395bed879007313b3335e0ea93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00277-021-04556-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00277-021-04556-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33982136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elzaeem, Doaa I.</creatorcontrib><creatorcontrib>Sharkawi, Esmat A. El</creatorcontrib><creatorcontrib>Zaki, Eman M.</creatorcontrib><creatorcontrib>Ghobrial, Ayman G.</creatorcontrib><creatorcontrib>El-Fatah, Aliaa S. Abd</creatorcontrib><creatorcontrib>El-Hamed, Waleed M. Abd</creatorcontrib><title>Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients</title><title>Annals of hematology</title><addtitle>Ann Hematol</addtitle><addtitle>Ann Hematol</addtitle><description>Immune thrombocytopenia (ITP) is a disorder in which autoantibodies are responsible for destruction and decreased production of platelets. In the meantime, thrombocytopenia is frequent in patients with myelodysplastic syndromes (MDS) and immune clearance of megakaryocytes could be a reason. The aim of the present study is to evaluate and compare IgG binding to megakaryocytes in bone marrow of ITP and MDS patients to determine megakaryocytes targeting by autoantibodies in vivo as a mechanism of platelet underproduction in these disorders. The study was carried out on 20 ITP (group I) patients, 20 thrombocytopenic patients with (MDS) (group II), and 20 non-ITP patients as a control (group III) who were admitted to Minia University Hospital. Serial histological sections from bone marrow biopsies were stained for IgG. All patients in group I and 50% of group II patients showed bleeding tendency and the difference was significant (p &lt; 0.001). No patient experienced fatigue in group I while 35% of patients in group II complained of easy fatigability, and the difference was significant (p &lt; 0.008). High IgG antibody binding was found in ITP and MDS compared to the control group but no significant difference between ITP and MDS patients (14/20 (70%) vs. 13/20 (65%)) (p value = 0.736). Antibody binding to megakaryocytes in a proportion of MDS patients suggests that immune-mediated mechanism underlies platelet underproduction in those patients.</description><subject>Bone marrow</subject><subject>Hematology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Myelodysplastic syndromes</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Thrombocytopenia</subject><issn>0939-5555</issn><issn>1432-0584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kU9v3CAQxVGVqNmk_QI9VEi59OIEGOM_x2qVJpEi5ZKeETbjrbcGXMCR_O3DdtNWyqFzGWn4zQPeI-QTZ1ecsfo6MibqumCCF6yUsirEO7LhJYiCyaY8IRvWQlvIXGfkPMY9Y1w0pXhPzgDaRnCoNmS_9XbWQafxGWlMi1mpH-j97pZ2ozOj29HkqcWd_qnD6vs1YaSjo6O1i0OqnaF2xcmbNc6TjmnsafoRvO0OqJ_R5cGcxdGl-IGcDnqK-PG1X5Dv326etnfFw-Pt_fbrQ9FDLVMBvKoaUyJ2oh66vgUjhsNH0IhKlpWuhJCdyQPZoWnqNjsBHDoAkMhQt3BBvhx15-B_LRiTsmPscZq0Q79EJaSogMkSWEYv36B7vwSXX5epkmXDai4yJY5UH3yMAQc1h9FmPxRn6pCEOiahchLqdxLqsPT5VXrpLJq_K3-szwAcgZiP3A7Dv7v_I_sCbHWUdA</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Elzaeem, Doaa I.</creator><creator>Sharkawi, Esmat A. El</creator><creator>Zaki, Eman M.</creator><creator>Ghobrial, Ayman G.</creator><creator>El-Fatah, Aliaa S. Abd</creator><creator>El-Hamed, Waleed M. Abd</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20210701</creationdate><title>Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients</title><author>Elzaeem, Doaa I. ; Sharkawi, Esmat A. El ; Zaki, Eman M. ; Ghobrial, Ayman G. ; El-Fatah, Aliaa S. Abd ; El-Hamed, Waleed M. Abd</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-31668d4eeb27fbc93d2f0939ed26546a6225bd9395bed879007313b3335e0ea93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Bone marrow</topic><topic>Hematology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Myelodysplastic syndromes</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Thrombocytopenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elzaeem, Doaa I.</creatorcontrib><creatorcontrib>Sharkawi, Esmat A. El</creatorcontrib><creatorcontrib>Zaki, Eman M.</creatorcontrib><creatorcontrib>Ghobrial, Ayman G.</creatorcontrib><creatorcontrib>El-Fatah, Aliaa S. Abd</creatorcontrib><creatorcontrib>El-Hamed, Waleed M. Abd</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elzaeem, Doaa I.</au><au>Sharkawi, Esmat A. El</au><au>Zaki, Eman M.</au><au>Ghobrial, Ayman G.</au><au>El-Fatah, Aliaa S. Abd</au><au>El-Hamed, Waleed M. Abd</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients</atitle><jtitle>Annals of hematology</jtitle><stitle>Ann Hematol</stitle><addtitle>Ann Hematol</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>100</volume><issue>7</issue><spage>1701</spage><epage>1709</epage><pages>1701-1709</pages><issn>0939-5555</issn><eissn>1432-0584</eissn><abstract>Immune thrombocytopenia (ITP) is a disorder in which autoantibodies are responsible for destruction and decreased production of platelets. In the meantime, thrombocytopenia is frequent in patients with myelodysplastic syndromes (MDS) and immune clearance of megakaryocytes could be a reason. The aim of the present study is to evaluate and compare IgG binding to megakaryocytes in bone marrow of ITP and MDS patients to determine megakaryocytes targeting by autoantibodies in vivo as a mechanism of platelet underproduction in these disorders. The study was carried out on 20 ITP (group I) patients, 20 thrombocytopenic patients with (MDS) (group II), and 20 non-ITP patients as a control (group III) who were admitted to Minia University Hospital. Serial histological sections from bone marrow biopsies were stained for IgG. All patients in group I and 50% of group II patients showed bleeding tendency and the difference was significant (p &lt; 0.001). No patient experienced fatigue in group I while 35% of patients in group II complained of easy fatigability, and the difference was significant (p &lt; 0.008). High IgG antibody binding was found in ITP and MDS compared to the control group but no significant difference between ITP and MDS patients (14/20 (70%) vs. 13/20 (65%)) (p value = 0.736). Antibody binding to megakaryocytes in a proportion of MDS patients suggests that immune-mediated mechanism underlies platelet underproduction in those patients.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33982136</pmid><doi>10.1007/s00277-021-04556-2</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0939-5555
ispartof Annals of hematology, 2021-07, Vol.100 (7), p.1701-1709
issn 0939-5555
1432-0584
language eng
recordid cdi_proquest_miscellaneous_2526305430
source SpringerLink Journals
subjects Bone marrow
Hematology
Medicine
Medicine & Public Health
Myelodysplastic syndromes
Oncology
Original Article
Thrombocytopenia
title Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A49%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20study%20of%20IgG%20binding%20to%20megakaryocytes%20in%20immune%20and%20myelodysplastic%20thrombocytopenic%20patients&rft.jtitle=Annals%20of%20hematology&rft.au=Elzaeem,%20Doaa%20I.&rft.date=2021-07-01&rft.volume=100&rft.issue=7&rft.spage=1701&rft.epage=1709&rft.pages=1701-1709&rft.issn=0939-5555&rft.eissn=1432-0584&rft_id=info:doi/10.1007/s00277-021-04556-2&rft_dat=%3Cproquest_cross%3E2526305430%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2540001712&rft_id=info:pmid/33982136&rfr_iscdi=true